Total Payments
$30,322
2024 Payments
$1,285
Companies
33
Transactions
561
Medicare Patients
17,684
Medicare Billing
$2.4M
Payment Breakdown by Category
Other$15,655 (51.6%)
Food & Beverage$12,767 (42.1%)
Consulting$1,350 (4.5%)
Education$550.04 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,655 | 18 | 51.6% |
| Food and Beverage | $12,767 | 534 | 42.1% |
| Consulting Fee | $1,350 | 1 | 4.5% |
| Education | $550.04 | 8 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $13,398 | 132 | $0 (2024) |
| Allergan, Inc. | $6,632 | 15 | $0 (2023) |
| Merz North America, Inc. | $2,259 | 14 | $0 (2023) |
| Janssen Biotech, Inc. | $1,319 | 62 | $0 (2024) |
| Amgen Inc. | $878.52 | 50 | $0 (2023) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $702.82 | 43 | $0 (2024) |
| PFIZER INC. | $627.00 | 36 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $593.46 | 31 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $557.63 | 30 | $0 (2024) |
| UCB, Inc. | $417.39 | 20 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,285 | 59 | Janssen Biotech, Inc. ($314.30) |
| 2023 | $10,674 | 64 | ABBVIE INC. ($9,455) |
| 2022 | $10,030 | 112 | Allergan, Inc. ($6,077) |
| 2021 | $2,954 | 101 | AbbVie Inc. ($705.19) |
| 2020 | $2,060 | 90 | AbbVie Inc. ($589.46) |
| 2019 | $1,823 | 77 | Merz North America, Inc. ($451.02) |
| 2018 | $1,230 | 45 | Celgene Corporation ($277.98) |
| 2017 | $266.51 | 13 | Janssen Biotech, Inc. ($146.35) |
All Payment Transactions
561 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $18.33 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Immunology | ||||||
| 10/04/2024 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 09/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.40 | General |
| Category: Immunology | ||||||
| 09/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Dermatology | ||||||
| 09/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $1.25 | General |
| Category: DERMATOLOGY | ||||||
| 08/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: Immunology | ||||||
| 08/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 5,643 | 54,180 | $2.2M | $875,238 |
| 2022 | 37 | 4,044 | 34,332 | $1.0M | $527,807 |
| 2021 | 38 | 4,305 | 41,097 | $1.0M | $520,849 |
| 2020 | 40 | 3,692 | 28,277 | $995,859 | $439,495 |
Total Patients
17,684
Total Services
157,886
Medicare Billing
$2.4M
Procedure Codes
157
All Medicare Procedures & Services
157 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| Q4248 | Dermacyte amniotic membrane allograft, per square centimeter | Office | 2023 | 18 | 276 | $378,525 | $229,974 | 60.8% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 189 | 215 | $262,994 | $109,790 | 41.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 835 | 835 | $179,651 | $67,831 | 37.8% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 128 | 45,501 | $159,235 | $58,763 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 690 | 930 | $157,862 | $57,229 | 36.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 463 | 548 | $122,922 | $45,704 | 37.2% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 83 | 94 | $109,570 | $45,075 | 41.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 535 | 598 | $129,424 | $38,076 | 29.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 652 | 839 | $111,326 | $30,016 | 27.0% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 117 | 203 | $61,230 | $23,156 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 171 | $51,574 | $16,346 | 31.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 485 | 2,429 | $33,172 | $12,703 | 38.3% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 55 | 58 | $44,230 | $12,430 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 96 | 96 | $31,459 | $11,665 | 37.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 60 | 63 | $32,492 | $11,375 | 35.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 178 | 256 | $26,895 | $9,969 | 37.1% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 41 | 44 | $41,798 | $9,348 | 22.4% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 23 | 25 | $19,592 | $8,412 | 42.9% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 59 | 59 | $29,707 | $7,732 | 26.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 55 | 58 | $16,943 | $7,297 | 43.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 166 | 188 | $18,362 | $6,779 | 36.9% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 26 | 27 | $17,296 | $6,022 | 34.8% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 30 | 32 | $18,630 | $4,726 | 25.4% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 73 | 76 | $11,643 | $3,646 | 31.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 65 | 65 | $8,136 | $3,497 | 43.0% |
About Dr. Christopher Rex, M.D
Dr. Christopher Rex, M.D is a MOHS-Micrographic Surgery healthcare provider based in Payson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2013. The National Provider Identifier (NPI) number assigned to this provider is 1083054571.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Rex, M.D has received a total of $30,322 in payments from pharmaceutical and medical device companies, with $1,285 received in 2024. These payments were reported across 561 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($15,655).
As a Medicare-enrolled provider, Rex has provided services to 17,684 Medicare beneficiaries, totaling 157,886 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 157 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Pediatric Dermatology, Pediatric Dermatology
- Location Payson, AZ
- Active Since 06/27/2013
- Last Updated 10/18/2024
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1083054571
Products in Payments
- SKYRIZI (Biological) $1,530
- XEOMIN (Biological) $888.52
- Otezla (Drug) $822.41
- TREMFYA (Drug) $633.72
- Humira (Biological) $539.82
- COSENTYX (Biological) $506.62
- EUCRISA (Drug) $471.97
- Xeomin (Biological) $419.65
- Cimzia (Drug) $417.39
- REMICADE (Biological) $406.07
- TALTZ (Drug) $358.21
- DUPIXENT (Biological) $340.65
- RINVOQ (Biological) $278.54
- DUOBRII (Drug) $271.75
- HUMIRA (Biological) $270.18
- ILUMYA (Biological) $263.26
- JUBLIA (Drug) $240.48
- Enbrel (Biological) $205.35
- AMELUZ (Drug) $190.84
- PICATO (Drug) $183.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.